[Mifepristone in the treatment of an elderly patient with adrenocorticotropic hormone-dependent Cushing syndrome].

Wu, L L; Zeng, H Y; Tang, X Y; Fan, G J

Wu, L L; Zeng, H Y; Tang, X Y; Fan, G J.

Afiliação

Wu LL; Department of Endocrinology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, China.
Zeng HY; Department of Endocrinology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, China.
Tang XY; Department of Endocrinology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, China.
Fan GJ; Department of Endocrinology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, China.

Zhonghua Nei Ke Za Zhi ; 61(5): 574-577, 2022 May 01.

Article em Zh | MEDLINE | ID: mdl-35488612

Assuntos

Síndrome de Cushing; Mifepristona; Hormônio Adrenocorticotrópico/uso terapêutico; Idoso; Humanos; Pacientes

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mifepristona / Síndrome de Cushing Limite: Aged / Humans Idioma: Zh Revista: Zhonghua Nei Ke Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google